Gilead's Remdesivir Wins 1st FDA Full Approval For COVID-19
The U.S. Food and Drug Administration on Thursday gave the green light to Gilead's antiviral drug remdesivir for treatment of hospitalized COVID-19 patients that are at least 12 years old, marking...To view the full article, register now.
Already a subscriber? Click here to view full article